Tag: Transcranial direct current stimulation
Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients
In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...
Flow Neuroscience receives Series A funding to advance tDCS depression treatment
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...
How stimulation is changing the future of mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...
Future stroke rehabilitation could include robotic therapy
At the North American Neuromodulation Society (NANS) virtual meeting (15–16 January), Dylan J Edwards, director of the Moss Rehabilitation Research Institute and director of...
Soterix wins IDE for depression treatment trial
Soterix Medical has announced that it received US Food and Drug Administration (FDA) investigational device exemption (IDE) to launch a trial of its non-invasive transcranial...
Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim
At the recent American Epilepsy Society Annual Meeting in New Orleans, USA, Neuroelectrics presented positive results from its clinical trial treating patients with drug...
Transcranial stimulation and/or physical therapy improves walking speed in Parkinson’s disease
Non-invasive brain stimulation and physical therapy—alone or in combination—improve some measures of walking ability in patients with Parkinson’s disease, concludes a clinical trial in...
